US 12,453,753 B2
Oxygenated cannabis skin therapy compositions and methods for producing the compositions
David Pauwels, Eureka, CA (US); and Tiffany Andersen, Eureka, CA (US)
Assigned to David Pauwels, Eureka, CA (US)
Appl. No. 17/612,945
Filed by David Pauwels, Eureka, CA (US); and Tiffany Andersen, Eureka, CA (US)
PCT Filed May 21, 2020, PCT No. PCT/US2020/034024
§ 371(c)(1), (2) Date Nov. 19, 2021,
PCT Pub. No. WO2020/237065, PCT Pub. Date Nov. 26, 2020.
Claims priority of provisional application 62/852,132, filed on May 23, 2019.
Prior Publication US 2022/0226416 A1, Jul. 21, 2022
Int. Cl. A61K 36/889 (2006.01); A61K 8/22 (2006.01); A61K 8/49 (2006.01); A61K 8/9794 (2017.01); A61K 31/352 (2006.01); A61K 36/73 (2006.01); A61Q 19/00 (2006.01); A61K 33/00 (2006.01)
CPC A61K 36/889 (2013.01) [A61K 8/22 (2013.01); A61K 8/498 (2013.01); A61K 8/9794 (2017.08); A61K 31/352 (2013.01); A61K 36/73 (2013.01); A61Q 19/00 (2013.01); A61K 33/00 (2013.01)] 20 Claims
 
1. An oxygenated Cannabis composition, comprising:
an ozonated coconut oil; and
a non-aqueous extract of medicinal or recreational Cannabis containing tetrahydrocannabinol (THC), wherein:
the composition is substantially free of cannabinol (CBN); and
the THC is present in an amount up to about 500 mg/mL.